
insitro
@insitro
Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale.
ID: 991393490381746176
https://www.insitro.com/ 01-05-2018 19:06:42
336 Tweet
6,6K Followers
94 Following

insitro CFO/CBO, Mary Rozenman, is going to #HLTH2024 for the “Algorithms & Assays” panel! Mary & other industry experts will chat about how #ML revolutionizes #drugdiscovery, from AI-developed therapies to⚡fast development 🔄. Break it down with us on the Gallery Stage October 22


Big ideas drive us. 🔥 Dive into the latest episode of #MeettheLeader where Daphne Koller & Linda Lacina explore how #AI is rewriting the rules of #drugdiscovery. 💊 🎙️Tune in ⬇️ tinyurl.com/4hfzrmv4

Join us!💡insitro CSO Philip Tagari discusses our approach on a live webinar event hosted by Genetic Engineering & Biotechnology News on Wed, Oct 30. Hear more how insitro is re-imagining target discovery w/ #ML & data-driven science. Register: webinars.liebertpub.com/e/The-State-of…





Big thanks to Brunswick Group’s Ben Hirschler who recently spoke with insitro CFO/CBO Mary Rozenman on the potential of #AI and machine learning in #drugdiscovery. This piece also shows how UK Biobank (and insitro partner) contributes to the success in developing therapeutics


Thanks to the San Francisco Business Times for including insitro CEO and founder Daphne Koller in their Newsmakers 100 list, recognizing the great partnerships and developments we announced with both Eli Lilly and Company and Bristol Myers Squibb in 2024. 🌟 Read more about Daphne and the other impressive


insitro CFO/CBO Mary Rozenman joins Biocom California Global Life Science Partnering & Investor Conference alongside #biotech and pharma peers for the “AI & Drug Discovery: It’s Not As Easy As It Looks” panel. Learn more at: biocom.org/conferences/gl…



Join insitro CEO and founder Daphne Koller at WIRED Health in London next Tuesday, March 18 as she takes the keynote stage!📣 Daphne will be sharing an inside look at how insitro’s approach to #drugdiscovery is building a pipeline of high-conviction targets through



The Keystone Symposia’s joint conference is coming up in Whistler, BC, Canada! insitro’s Director Max Salick will be presenting at “The Digital Era in Neurodegeneration and Neuroinflammation” to share recent research and technological advances on our POSH platform from the insitro



